Sinopharm’s AI Odyssey: Transforming Healthcare from Vaccines to Comprehensive Solutions
In the rapidly evolving landscape of artificial intelligence (AI) and pharmaceuticals, Sinopharm Group Co., Ltd. emerges as a prominent player. This Chinese pharmaceutical giant, established through a joint venture between the state-owned China National Pharmaceutical Group and the civilian-run Fosun Pharmaceutical, has made significant strides in the development of innovative healthcare solutions. Financial Milestones Sinopharm…